0001104659-18-016854.txt : 20180312
0001104659-18-016854.hdr.sgml : 20180312
20180312203224
ACCESSION NUMBER: 0001104659-18-016854
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180228
FILED AS OF DATE: 20180312
DATE AS OF CHANGE: 20180312
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GOLDENBERG DAVID M
CENTRAL INDEX KEY: 0001029578
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-12104
FILM NUMBER: 18684993
MAIL ADDRESS:
STREET 1: UBS GLOBAL ASSET MANAGEMENT (US) INC.
STREET 2: 51 WEST 52ND STREET
CITY: NEW YORK
STATE: NY
ZIP: 10019
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IMMUNOMEDICS INC
CENTRAL INDEX KEY: 0000722830
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 611009366
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 300 AMERICAN RD
CITY: MORRIS PLAINS
STATE: NJ
ZIP: 07950
BUSINESS PHONE: 9736058200
MAIL ADDRESS:
STREET 1: 300 AMERICAN ROAD
CITY: MORRIS PLAINS
STATE: NJ
ZIP: 07950
4
1
a4.xml
4
X0306
4
2018-02-28
0
0000722830
IMMUNOMEDICS INC
IMMU
0001029578
GOLDENBERG DAVID M
C/O IMMUNOMEDICS, INC
300 THE AMERICAN ROAD
MORRIS PLAINS
NJ
07950
1
0
0
0
Common Stock
2018-03-07
4
S
0
20000
17.50
D
1774285
D
Common Stock
2018-02-28
4
S
0
17729
17.09
D
5693252
I
See Footnote
Common Stock
2018-03-05
4
S
0
20000
17.30
D
5673252
I
See Footnote
Common Stock
2018-03-05
4
S
0
20000
17.17
D
5653252
I
See Footnote
Common Stock
2018-03-07
4
S
0
20000
17.60
D
5633252
I
See Footnote
Common Stock
2018-03-07
4
S
0
20000
17.75
D
5613252
I
See Footnote
Such shares were held by the reporting person's spouse, Ms. Cynthia L. Goldenberg, also known as Cynthia L. Sullivan.
Includes a total of 635,935 shares held as joint tenants by the reporting person and his spouse, Ms. Cynthia L. Goldenberg, also known as Cynthia L. Sullivan, a director of the Company.
Such shares are held by the reporting person's spouse, by various trusts established for the benefit of the reporting person and/or family members of the reporting person, or by a majority-owned subsidiary of the Issuer. The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interests therein.
/s/ Dr. David M. Goldenberg
2018-03-12